Fusion event
HBV-LINC02107 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Region type
precore/core protein|Core and e antigen|
Integrated sequence
ATGCAACTTTTTCACCTCTGCCTAATCATCTCTTGTTCATGTCCTACTGTTCAAGCCTCCAAGCTGTGCCTTGGGTGGCTTTGGGGCATGGACATCGACC| |CTTATAAAGAATTTGGAGCTACTGTGGAGTTACTCTCGTTTTTGCCTTCTGACTTCTTTCCTTCAGTACGAGATCTTCTAGATACCGCCTCAGCTCTGTA
End
38068465/38068363 (Hg38)
Nearest miRNA
hsa-mir-10397/Upstream/1920375; hsa-mir-103a-1/Downstream/489139;
Upstream sequence
acacaatcatagctcactgcagccttgaacttctgggctcaagcgatcttccagcctcagcatcagagaagctaggactacaggcatgcaccaccatggg
Downstream sequence
CAGAGCTGTCAACTGCTAGACAGCTTTTGCAGCCACTCTTCTGCACATCTCAATACTAAAGAGAGGGTCACTTTCAACTGGCACATTTAATAATGTCACC
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.